Diastolic intraventricular gradient in hypertrophic cardiomyopathy with apical hypertrophy

H Keller1, V von Kageneck, J Buss

  • 1I. Medizinische Klinik Mannheim der Universität Heidelberg.

Insights

This case report details rare apical hypertrophic cardiomyopathy with complete systolic obstruction. It highlights a unique holodiastolic intraventricular pressure gradient in a patient with hypertrophic cardiomyopathy.

Area of Science:

  • Cardiology
  • Cardiovascular Physiology
  • Medical Case Reports

Background:

  • Hypertrophic cardiomyopathy (HCM) is a complex cardiac condition characterized by unexplained left ventricular hypertrophy.
  • Diastolic dysfunction is a common feature of HCM, but significant diastolic flow abnormalities are less frequently observed.
  • Apical hypertrophic cardiomyopathy (AHCM) represents a specific subtype, often presenting with distinct clinical and hemodynamic characteristics.

Observation:

  • This report focuses on a rare presentation of AHCM.
  • The patient exhibited complete systolic obstruction, a severe manifestation of the condition.
  • A notable holodiastolic intraventricular pressure gradient was identified, indicating abnormal diastolic filling patterns.

Findings:

  • The case demonstrates a unique combination of apical ventricular hypertrophy, complete systolic obstruction, and a holodiastolic intraventricular pressure gradient.
  • This specific hemodynamic profile is not commonly described in the literature for AHCM.
  • The findings underscore the diverse and complex pathophysiology that can occur within hypertrophic cardiomyopathy.

Implications:

  • This case contributes to the understanding of rare variants of hypertrophic cardiomyopathy and their associated hemodynamic abnormalities.
  • It emphasizes the importance of comprehensive diagnostic evaluation, including advanced imaging and pressure gradient assessment, in managing complex HCM cases.
  • Further research into such rare presentations may refine diagnostic criteria and therapeutic strategies for hypertrophic cardiomyopathy.

Related Concept Videos

Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...